Levity vs myRocky
Levity costs $210 less a month, and both sell semaglutide and tirzepatide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
If you are choosing between Levity and myRocky, the first difference is cost: Levity is $210 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Levity leads our six-part score, 7.2 to 5.6. One of the two has an FDA warning letter on record, covered below.
Levity vs myRocky price
Levity is the cheaper way in: $1,199 a month against $1,409 a month at myRocky. That is $210 less each month (15% lower), or about $2,520 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Levity ($1,199 a month vs $1,409 a month); tirzepatide is cheaper at Levity ($1,299 a month vs $1,409 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format they match: each offers brand-name pens.
Where each one treats patients
Levity lists 36 states, and myRocky does not publish where it ships.
Pricing
Levity
myRocky
What each price covers
Levity's price also covers the clinician visit, the medication itself and shipping, which myRocky does not claim.
Levity is silent on lab work and coaching.
myRocky does not say what its price includes.
That matters most for the drug: unless myRocky confirms otherwise, budget for medication on top of its listed price.
Levity
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
myRocky
Inclusions not disclosed.
Where each one scores higher
Overall, Levity scores 7.2 and myRocky 5.6 out of 10.
Levity is stronger on value (4.7 vs 4.1), user experience (8.0 vs 3.0), trust & safety (5.5 vs 4.0), accessibility (7.8 vs 5.0) and support (7.0 vs 5.0).
Effectiveness is within half a point.
Levity
7.2/10
myRocky
5.6/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Levity a warning letter dated February 20, 2026 (letter 717990), and it is still open.
myRocky has no FDA warning letter on record with us.
Features & Coverage
| Feature | Levity | myRocky |
|---|---|---|
| Starting Price | ✓$1,199/mo | $1,409/mo |
| Features | 8 features | 8 features |
| States Available | 36 | Not disclosed |
| Compounded | — | — |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | 1 letter | ✓None |
About Levity
Expect between 1,199 and 1,599 dollars a month once the first-month discount falls away, the exact figure depending on which drug. That single monthly fee absorbs the prescription, the consultation, delivery, follow-up care and clinical support without limit. No compounded GLP-1 is dispensed. Levity carries only FDA-approved branded products, Mounjaro (tirzepatide), Wegovy (semaglutide) and Ozempic (semaglutide), each a weekly injectable pen. A LegitScript badge is displayed and both pharmacy and physician leaders are named. It operates in 34 states, with progress tracking.
Read our full Levity review →About myRocky
The fees pile up: $99 to consult at the start, then $99/month as a program fee, and the medication on top of that, with Ozempic shown at roughly $1,409/month. Rocky Health Inc. is incorporated in Ontario, Canada and sells brand-name drugs, Ozempic, Mounjaro and Wegovy, into the US market; nothing compounded is offered. The same subscription also reaches sexual health, hair loss and mental health.
Read our full myRocky review →Pros & Cons
Levity
What we like
- Tirzepatide costs $1299 a month, close to the $1249 median for brand-name tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
Watch-outs
- Semaglutide costs $1199 a month, 20% above the $997 median for brand-name semaglutide across the sellers we compare
- Serves only 36 states, so check that yours is one of them
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued Levity a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
myRocky
What we like
- Tirzepatide costs $1409 a month, close to the $1249 median for brand-name tirzepatide across the sellers we compare
- We found no FDA warning letters issued to myRocky
Watch-outs
- Semaglutide costs $1409 a month, 41% above the $997 median for brand-name semaglutide across the sellers we compare
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Our Verdict
Levity wins this one, 7.2 to 5.6, above all for semaglutide from $1199/month. It also costs $210 less each month than myRocky. myRocky fits better if a GLP-1 from $1409/month is your priority.
Choose Levity if…
You want semaglutide from $1199/month and an opening price near $1,199 a month.
Choose myRocky if…
You want a GLP-1 from $1409/month and an opening price near $1,409 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
DudeMeds
Compounded semaglutide at $175/month
From $175/mo
Get started →Oak
Semaglutide at $119/month, 37% below the typical price
From $119/mo
Get started →Trimi Health
Knowing which pharmacy fills the vial: it names VialsRx
From $99/mo
Get started →Levity vs myRocky: FAQ
Close alternatives to Levity and myRocky
- Levity vs Form Health
- Levity vs TrimRx
- Levity vs Klinic
- myRocky vs Form Health
- myRocky vs TrimRx
- myRocky vs Klinic
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.